Treasury Chief Reeves Intends Targeted Action on Household Expenses in Forthcoming Budget

Treasury head Rachel Reeves has revealed she is preparing "targeted action to address household expense issues" in next month's Budget.

During an interview with media outlets, she emphasized that lowering price rises is a collective task of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the most elevated among the G7 advanced economies this calendar year and next.

Potential Utility Cost Measures

It is understood the government could take action to reduce utility costs, such as by slashing the current 5% level of VAT charged on energy supplies.

Another possibility is to reduce some of the regulatory levies currently included in bills.

Fiscal Constraints and Analyst Predictions

The administration will receive the next report from the independent fiscal watchdog, the OBR, on Monday, which will show how much scope there is for these measures.

The consensus from most analysts is that Reeves will have to introduce higher taxes or spending cuts in order to meet her voluntary debt limits.

Previously on the same day, calculations suggested there was a £22 billion shortfall for the chancellor to resolve, which is at the more modest range of forecasts.

"It is a collective task between the Bank of England and the administration to bear down further on some of the drivers of price increases," the Chancellor informed reporters in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Pledges and International Concerns

While a great deal of the attention has been on likely tax increases, the chancellor said the most recent figures from the OBR had not changed her pledge to campaign commitments not to raise rates on earnings tax, sales tax or social security contributions.

She attributed an "unpredictable global environment" with increasing geopolitical and commercial concerns for the Budget revenue measures, likely to be directed on those "most able to pay."

International Trade Disputes

Commenting on concerns about the UK's commercial links with China she said: "Our national security invariably take priority."

Last week's statement by Chinese authorities to increase trade restrictions on critical minerals and other materials that are crucial for high-technology manufacturing led American leader the US President to suggest an extra 100% import tax on imports from China, raising the risk of an all-out trade war between the two global powers.

The American finance chief called China's action "economic coercion" and "a international production power grab."

Asked about accepting the American proposal to join its dispute with China, the Chancellor said she was "very concerned" by China's actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the move was "damaging for the international commerce and causes further challenges."

"In my view there are areas where we should address Chinese policies, but there are also valuable chances to export to Chinese markets, including financial services and other areas of the economic system. We've got to maintain that balance right."

The chancellor also stated she was cooperating with G7 counterparts "regarding our own critical minerals approach, so that we are more independent."

NHS Drug Pricing and Funding

The Chancellor also recognized that the cost the NHS pays for pharmaceuticals could go up as a result of ongoing talks with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or abandoning operations in the United Kingdom, with some attributing the low prices they are receiving.

Last month, the Science Minister said the cost the health service spends on medicines would have to go up to halt businesses and pharmaceutical investment leaving the UK.

Reeves told media: "It has been observed due to the pricing regime, that medical research, innovative medicines have not been provided in the United Kingdom in the way that they are in other European countries."

"The objective is to ensure that patients getting care from the NHS are able to access the finest critical drugs in the world. And so we are looking at these issues, and... aiming to obtain more capital into the UK."